HIV drug resistance: brief report 2024
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment. In this report, WHO documents
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment. In this report, WHO documents
For US armed forces it is now adieu metals, and welcome plastics. Researchers at Stevens Institute of Technology have designed plastic-composite nosecones for shoulder-fired missiles for the marines.
The Union government plans to introduce a bill in the Parliament to institute a national drug authority which would monitor and control the manufacture and marketing of drugs in India. Although a
To meet its objective of health for all by AD 2000, Bangladesh has decided to open its doors for importing pharmaceutical ingredients, packaging products and finished drugs. Medicines inadequately
A simple, selective and sensitive high-performance liquid chromatographic (HPLC) method has been developed for the measurement of josamycin residues in four porcine tissues (i.e., muscle, liver, kidney and fat).
In this GATT era, Indian drugs and pharmaceutical scientists have belatedly begun to focus on drug, rather than on process, development
To do or not to do: is keeping narcotics illicit helping the underworld?
The Union ministry of environment and forests (MEF) is caught in middle of a raging debate over the use of monkeys in the manufacture of oral polio vaccine (OPV). While the Maharashtra government has
The Lucknow-based Central Drug Research Institute (cdri) is awaiting permission from the Drug Controller of India to commence the testing of a memory drug among human volunteers. cdri director V P
THE defining feature of modern, Western medical perception is the dominance of the laboratory -- it is the biomedical laboratory which determines whether you are 'sick' or 'healthy', it gives you the
The German pharmaceutical giant Schering AG is in for a hard time. Androcur and Diane 35, 2 of its best-selling drugs marketed in Europe, are suspected to be potential causes of cancer. Tests carried